Home › Companies › VERA THERAPEUTICS INC. › 2023-2024
At VERA THERAPEUTICS INC.'s shareholder meeting held May 15, 2024, in the 2023-2024 proxy season, 58 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 498 separate fund positions. On the most widely held item on that ballot — To elect the two Class III directors named below to hold office until the Company's 2027 annual… — VERA THERAPEUTICS INC.'s filing reports the nominee as elected, with 68% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VERA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 17, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VERA THERAPEUTICS INC.’s Form 8-K, filed May 17, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 15, 2024: 3 items on VERA THERAPEUTICS INC.’s Form 8-K, filed May 17, 2024: 2 elected · 1 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VERA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VERA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Andrew Cheng, M.D., Ph.D. | 27,436,839 | -- | -- | 12,964,536 | 1,020,833 | 68% | Elected | — |
| Elect Director: Scott Morrison | 31,636,040 | -- | -- | 8,765,335 | 1,020,833 | 78% | Elected | — |
| 2. Ratification of the Selection of Independent Registered Public Accounting Firm | 41,413,260 | 1,832 | 7,116 | -- | -- | 99.9% | Approved | — |
Source: VERA THERAPEUTICS INC., Form 8-K, filed with the SEC on May 17, 2024 — read the filing on EDGAR.
Each item below shows how the 58 asset managers that disclosed a VERA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: To elect the two Class III directors named below to hold office until the Company's 2027 annual meeting of stockholders: Andrew Cheng, M.D., Ph.D.
VERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Andrew Cheng, M.D., Ph.D.”): 27,436,839 for, 12,964,536 withheld, per its Form 8-K filed May 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three persons listed below as Class III Directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director's death, resignati…”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,866,936 | 0 | 0 | 16,862 | For |
| Vanguard | 2,023,443 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 1,808,388 | Withhold |
| State Street | 1,607 | 0 | 0 | 1,571,827 | Withhold |
| BlackRock | 0 | 0 | 0 | 1,524,536 | Withhold |
| Charles Schwab | 326,438 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 268,934 | Withhold |
| Equitable | 0 | 0 | 0 | 123,680 | Withhold |
| TIAA | 69,198 | 0 | 0 | 0 | For |
| Prudential/PGIM | 41,859 | 0 | 0 | 24,017 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 61,732 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 60,297 | Withhold |
| Lord Abbett | 0 | 0 | 0 | 59,020 | Withhold |
| John Hancock | 0 | 0 | 40,061 | 0 | Abstain |
| Nushares ETF Trust | 39,107 | 0 | 0 | 0 | For |
| SEI | 37,217 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 35,001 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 32,856 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 28,200 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 25,185 | Withhold |
| Northern Trust | 0 | 0 | 0 | 21,898 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 18,160 | Withhold |
| Global X | 16,192 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 0 | 0 | 0 | 14,182 | Withhold |
| Pacific Life | 0 | 0 | 0 | 12,750 | Withhold |
Fund voting reports, all 57 managers: 5,449,497 for, 5,805,249 withheld, 51,527 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 710,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 710,000 for.
Combines 4 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: To elect the two Class III directors named below to hold office until the Company's 2027 annual meeting of stockholders: Scott Morrison
VERA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Scott Morrison”): 31,636,040 for, 8,765,335 withheld, per its Form 8-K filed May 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three persons listed below as Class III Directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director's death, resignati…”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,866,936 | 0 | 0 | 16,862 | For |
| Vanguard | 2,023,443 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,808,388 | 0 | 0 | 0 | For |
| State Street | 3,385 | 0 | 0 | 1,570,049 | Withhold |
| BlackRock | 0 | 0 | 0 | 1,524,536 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 326,438 | Withhold |
| Invesco | 0 | 0 | 0 | 268,934 | Withhold |
| Equitable | 32,304 | 0 | 0 | 91,376 | Mixed |
| TIAA | 69,198 | 0 | 0 | 0 | For |
| Prudential/PGIM | 65,876 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 61,732 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 60,297 | Withhold |
| Lord Abbett | 59,020 | 0 | 0 | 0 | For |
| John Hancock | 40,061 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 39,107 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 37,217 | Withhold |
| ProShares | 35,001 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 32,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 28,200 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 25,185 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 21,898 | Withhold |
| AIG/SunAmerica | 18,160 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 16,192 | Withhold |
| RBB FUND, INC. | 14,182 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 12,750 | Withhold |
Fund voting reports, all 57 managers: 7,283,265 for, 4,011,344 withheld, 11,664 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 710,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 710,000 for.
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
VERA THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 41,413,260 for, 1,832 against — passed, per its Form 8-K filed May 17, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending Dece…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,883,798 | 0 | 0 | 0 | For |
| Vanguard | 2,023,443 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,808,388 | 0 | 0 | 0 | For |
| State Street | 1,573,434 | 0 | 0 | 0 | For |
| BlackRock | 1,524,536 | 0 | 0 | 0 | For |
| Charles Schwab | 326,438 | 0 | 0 | 0 | For |
| Invesco | 268,934 | 0 | 0 | 0 | For |
| Equitable | 123,680 | 0 | 0 | 0 | For |
| TIAA | 69,198 | 0 | 0 | 0 | For |
| Prudential/PGIM | 65,876 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 61,732 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 60,297 | 0 | 0 | 0 | For |
| Lord Abbett | 59,020 | 0 | 0 | 0 | For |
| John Hancock | 40,061 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 39,107 | 0 | 0 | 0 | For |
| SEI | 37,217 | 0 | 0 | 0 | For |
| ProShares | 35,001 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 32,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 28,200 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 25,185 | 0 | 0 | 0 | For |
| Northern Trust | 21,898 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,160 | 0 | 0 | 0 | For |
| Global X | 16,192 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 14,182 | 0 | 0 | 0 | For |
| Pacific Life | 12,750 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 11,306,273 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 710,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 710,000 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 54,701,217 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 5.27% |
| 2 | Vanguard | 3.70% |
| 3 | T. Rowe Price | 3.31% |
| 4 | State Street | 2.88% |
| 5 | BlackRock | 2.79% |
| 6 | Charles Schwab | 0.60% |
| 7 | Invesco | 0.49% |
| 8 | Equitable | 0.23% |
| 9 | TIAA | 0.13% |
| 10 | Prudential/PGIM | 0.12% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Altium Capital Management LP | 1.30% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Avoro Capital Advisors LLC | 10.26% | 13G |
| BlackRock | 7.76% | 13F |
| Deerfield Mgmt, L.P. | 6.12% | 13G |
| Vanguard Group | 5.83% | 13F |
| FMR (Fidelity) | 5.20% | 13F |
| T. Rowe Price | 4.37% | 13F |
| State Street | 4.30% | 13F |
| Ares Trading SA | 3.50% | 13G |
| Kynam Capital Management, LP | 2.88% | 13G |
| Point72 | 2.15% | 13F |
Percentages above are of 54,701,217 shares outstanding, as reported by VERA THERAPEUTICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERA THERAPEUTICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
VERA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “VERA THERAPEUTICS (VERA) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/vera-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.